New drug trial offers hope for chronic Meniere's disease sufferers

NCT ID NCT06859788

Recruiting now Disease control Sponsor: Sound Pharmaceuticals, Incorporated Source: ClinicalTrials.gov ↗

Summary

This study is testing whether SPI-1005 is safe for long-term use in adults with Meniere's disease. Participants will take the medication for 6 to 12 months to help control symptoms like vertigo, hearing loss, and tinnitus. The goal is to determine if this treatment can be used safely over extended periods to manage this chronic condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

ENT and Allergy Associates of Florida
RECRUITING

Boca Raton, Florida, 33487, United States

Contact Phone: •••-•••-••••
ENT and Allergy Associates, LLP
NOT_YET_RECRUITING

New York, New York, 10017, United States
Medical College of Wisconsin
NOT_YET_RECRUITING

Milwaukee, Wisconsin, 53226, United States

Contact Phone: •••-•••-••••
Medical University of South Carolina
RECRUITING

Charleston, South Carolina, 29425, United States

Contact Phone: •••-•••-••••
Northwell Health
RECRUITING

New Hyde Park, New York, 11042, United States

Contact Phone: •••-•••-••••
The House Institute
RECRUITING

Los Angeles, California, 90057, United States

Contact Phone: •••-•••-••••
University of Miami
NOT_YET_RECRUITING

Miami, Florida, 33136, United States
University of Texas Southwestern
NOT_YET_RECRUITING

Dallas, Texas, 75390, United States

Conditions

Explore the condition pages connected to this study.

MENIERE'S DISEASE MÉNIÈRE'S DISEASE